Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,711 | 105 | 97.0% |
| Education | $114.57 | 10 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $769.10 | 37 | $0 (2024) |
| ABBVIE INC. | $419.80 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $416.62 | 14 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $405.43 | 4 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $389.77 | 6 | $0 (2024) |
| Allergan Inc. | $291.17 | 10 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $265.70 | 26 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $250.00 | 2 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $152.69 | 2 | $0 (2021) |
| Amgen Inc. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,161 | 18 | Neurocrine Biosciences, Inc. ($317.04) |
| 2023 | $457.34 | 9 | AbbVie Inc. ($178.03) |
| 2022 | $176.91 | 8 | Alkermes, Inc. ($103.66) |
| 2021 | $522.46 | 15 | Alkermes, Inc. ($203.31) |
| 2020 | $132.47 | 7 | Alkermes, Inc. ($89.60) |
| 2019 | $340.94 | 14 | Allergan Inc. ($152.50) |
| 2018 | $455.86 | 25 | Allergan Inc. ($138.67) |
| 2017 | $579.06 | 19 | Avanir Pharmaceuticals, Inc. ($405.43) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: CNS | ||||||
| 11/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Neuroscience | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $42.09 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $171.61 | General |
| Category: Neuropsychiatry | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 06/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: CNS | ||||||
| 06/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: Neuroscience | ||||||
| 06/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: Neuroscience | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $145.43 | General |
| Category: Neuropsychiatry | ||||||
| 05/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $128.04 | General |
| Category: Neuroscience | ||||||
| 04/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 04/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Neuroscience | ||||||
| 04/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: CNS | ||||||
| 02/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $41.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/03/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: CNS | ||||||
| 07/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: CNS | ||||||
| 06/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: CNS | ||||||
| 04/24/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: CNS | ||||||
| 02/24/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: CNS | ||||||
| 01/28/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $152.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 95 | $10,314 | $5,077 |
| 2022 | 1 | 13 | 52 | $5,445 | $3,109 |
| 2021 | 2 | 30 | 106 | $11,560 | $5,852 |
| 2020 | 1 | 11 | 33 | $3,455 | $1,669 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 60 | $6,283 | $3,463 | 55.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 35 | $4,031 | $1,614 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 52 | $5,445 | $3,109 | 57.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 62 | $6,492 | $3,643 | 56.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 13 | 44 | $5,068 | $2,210 | 43.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 33 | $3,455 | $1,669 | 48.3% |
About Dr. Alan Buffenstein, M.D
Dr. Alan Buffenstein, M.D is a Psychiatry healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639278104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Buffenstein, M.D has received a total of $3,826 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 115 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,711).
As a Medicare-enrolled provider, Buffenstein has provided services to 81 Medicare beneficiaries, totaling 286 services with total Medicare billing of $15,708. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry, Pain Medicine
- Location Honolulu, HI
- Active Since 09/21/2006
- Last Updated 02/01/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639278104
Products in Payments
- ARISTADA (Drug) $707.03
- INVEGA SUSTENNA (Drug) $389.98
- INGREZZA (Drug) $389.77
- ULTOMIRIS (Biological) $250.00
- VRAYLAR (Drug) $242.90
- ONZETRA Xsail (Drug) $228.19
- BOTOX (Biological) $193.70
- NURTEC ODT (Drug) $184.10
- UBRELVY (Drug) $129.06
- Aimovig (Biological) $125.00
- BOTOX (Drug) $125.00
- UPLIZNA (Drug) $125.00
- XCOPRI (Drug) $125.00
- ABILIFY MAINTENA (Drug) $124.43
- NUEDEXTA (Drug) $100.71
- REXULTI (Drug) $73.08
- Aristada 441 mg (Drug) $62.07
- AUSTEDO (Drug) $44.26
- SPRAVATO (Drug) $26.64
- BYSTOLIC (Drug) $20.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Honolulu
Dr. Denis Mee-Lee, Md, MD
Psychiatry — Payments: $520,826
Dr. David Stein, M.d, M.D
Psychiatry — Payments: $209,598
Dr. Peter Dee, Md, MD
Psychiatry — Payments: $59,404
Dr. Jon Cooney, Md, MD
Psychiatry — Payments: $24,667
Dr. Gregory Yuen, M.d, M.D
Psychiatry — Payments: $7,901
Raymond Davidson, M.d, M.D
Psychiatry — Payments: $5,748